Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Adamis, AIM Immunotech, Altimmune, Astellas, Astrazeneca, Beigene, Biontech, Celltrion, Curocell, Cytocom, Daiichi Sankyo, Dr. Reddy’s, Janssen-Cilag, JCR, Johnson & Johnson, Junshi, Pfizer, Pharmamar, RDIF, Seagen.